uBiome Launches ExplorerPlus™ Metagenomic Sequencing-Based Product that Includes Viruses, Fungi, and Functional Genes, as well as Bacteria and Archaea

Share Article

ExplorerPlus uses precision sequencing™, uBiome’s patented combination of full metagenomic and marker-based sequencing, to offer a broader view on the microbiome than ever before.

ExplorerPlus is the next step in the evolution of uBiome’s products to more fully understand the human microbiome in the context of health and wellness.

uBiome, the leader in microbial genomics, announced today the launch of ExplorerPlus
the next generation of its popular Explorer™ health and wellness product. ExplorerPlus uses uBiome’s precision sequencing™ platform, a patented combination of full metagenomic and marker-based sequencing that allows users to see more of their microbiome -- including viruses and fungi in addition to archaea (single-celled microorganisms) and bacteria. ExplorerPlus offers consumers insights on the key metabolites and vitamins that are being synthesized by the bacteria in their microbiome, more comprehensive information on probiotic bacteria, and downloadable raw data for every organism detected in their sample.

Explorer has been used by hundreds of thousands of consumers in almost every country in the world, as well as by more than 200 prestigious research institutions around the world. Citizen scientists and wellness enthusiasts have enjoyed learning more about their microbiomes in the context of health and wellness. ExplorerPlus will allow these users to learn more about their samples and to participate in expanded research opportunities.

“ExplorerPlus is the next generation of uBiome’s original Explorer product, which will now include viruses, fungi, and functional genes as well as bacteria and archaea. This technology is now available for consumers,” said Dr. Jessica Richman, uBiome co-founder and CEO. “ExplorerPlus is the next step in the evolution of uBiome’s products to more fully understand the human microbiome in the context of health and wellness.”

In 2016, uBiome brought to market SmartGut™, the world’s first sequencing-based clinical microbiome test, providing patients and doctors with actionable insights to improve gut health for patients with chronic bowel conditions. In 2017, uBiome launched SmartJane™, the world’s first women’s health test, to genotype all clinically relevant strains of human papillomavirus (HPV) in addition to screening for sexually transmitted infections (STIs) and imbalances in vaginal flora. The launch of ExplorerPlus is the first launch in 2018.

Customers can click here to pre-order ExplorerPlus, which will be shipped in Spring 2018. Customers who pre-order will also receive a 50% discount off of the launch price for a limited time, while supplies last.

uBiome is also offering customers product discounts for purchasing a subscription and a chance to upgrade a previously purchased Gut Explorer sample to ExplorerPlus.

Existing Explorer users who have questions can reach out to uBiome customer support by emailing [email protected]

About uBiome

Founded in 2012, uBiome is the world’s leading microbial genomics company with a mission to explore important research questions about the microbiome and develop reliable, accurate products and services, focused on the microbiome. uBiome is funded by Y Combinator, Andreessen Horowitz, 8VC and other leading investors. uBiome’s mission is to transform the science of the microbiome into useful products and services that improve people’s lives.

Press Contacts
Mary Lewis
mary.lewis(at)ubiome.com

Lelle Henrichsen
lelle.henrichsen(at)ubiome.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mary Lewis
uBiome
+1 (415) 842-2466
Email >
@uBiome
Follow >
Follow us on
Visit website